Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

Why Are Moderna Executives Dumping Their Stock?

Analysis by Dr. Joseph Mercola Fact Checked

Story at-a-glance

  • Results from Moderna’s Phase 1 human trial revealed the 100-mcg dose vaccine — which had a 100% side effect ratio after the second dose — is proceeding to Phase 3 trial assessment

WARNING!

This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.

Top

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Service.